Arena Pharmaceuticals, Inc. (ARNA): Price and Financial Metrics


Arena Pharmaceuticals, Inc. (ARNA)

Today's Latest Price: $44.51 USD

1.30 (-2.84%)

Updated Jan 24 5:20pm

Add ARNA to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 322 in Biotech

See all "A" rated Strong Buy stocks

ARNA Stock Summary

  • ARNA's current price/earnings ratio is 4.08, which is higher than just 3.89% of US stocks with positive earnings.
  • Over the past twelve months, ARNA has reported earnings growth of -628.2%, putting it ahead of just 2.41% of US stocks in our set.
  • Revenue growth over the past 12 months for Arena Pharmaceuticals Inc comes in at 8,363.54%, a number that bests 99.88% of the US stocks we're tracking.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Arena Pharmaceuticals Inc are RGLS, STML, AEZS, PULM, and SHIP.
  • ARNA's SEC filings can be seen here. And to visit Arena Pharmaceuticals Inc's official web site, go to www.arenapharm.com.
ARNA Daily Price Range
ARNA 52-Week Price Range

ARNA Stock Price Chart More Charts


ARNA Price/Volume Stats

Current price $44.51 52-week high $64.48
Prev. close $45.81 52-week low $42.48
Day low $44.25 Volume 533,510
Day high $46.34 Avg. volume 455,181
50-day MA $46.46 Dividend yield N/A
200-day MA $51.40 Market Cap 2.23B

Arena Pharmaceuticals, Inc. (ARNA) Company Bio


Arena Pharmaceuticals is a biopharmaceutical company focused on discovering, developing and commercializing drugs to address unmet medical needs. The company was founded in 1997 and is based in San Diego, California.





ARNA Latest News Stream


Event/Time News Detail
Loading, please wait...

ARNA Latest Social Stream


Loading social stream, please wait...

View Full ARNA Social Stream

ARNA Price Returns

1-mo -3.34%
3-mo -9.57%
6-mo -29.49%
1-year -0.13%
3-year 209.10%
5-year -6.69%
YTD -2.00%
2019 16.61%
2018 14.66%
2017 139.23%
2016 -25.26%
2015 -45.24%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.5287 seconds.